Organoids grown from a patient’s own tissue keep the genetic and biological diversity that conventional cell lines and animal models often lose. That makes them powerful tools for understanding disease and guiding treatment decisions. Researchers are moving patient-derived organoids from the bench into practical use for disease modeling, drug screening, and response prediction.
In this Biocompare webinar, Dennis Plenker and Herve Tiriac will discuss patient model technologies and how organoids are generated from patient samples. From there, they will show how organoid platforms can be used for screening to better understand pathways behind health and disease.
Topics to be covered:
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.